Squarepoint
TIL icon

Squarepoint’s Instil Bio TIL Stock Holding History

Squarepoint’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,374
Closed -$362K – 5495
2024
Q3 		$362K Buy
+5,374
New +$127K ﹤0.01% 3326
2024
Q2 		– Sell
-17,367
Closed -$188K – 4650
2024
Q1 		$188K Sell
17,367
-10,469
-38% -$115K ﹤0.01% 3631
2023
Q4 		$212K Buy
27,836
+13,689
+97% +$99K ﹤0.01% 3560
2023
Q3 		$121K Buy
14,147
+3,033
+27% +$30.6K ﹤0.01% 3532
2023
Q2 		$122K Buy
11,114
+7,997
+257% +$97.7K ﹤0.01% 3323
2023
Q1 		$41.2K Sell
3,117
-25,019
-89% -$370K ﹤0.01% 3075
2022
Q4 		$355K Buy
+28,136
New +$1.39M ﹤0.01% 2478
2022
Q3 		– Sell
-841
Closed -$78K – 3439
2022
Q2 		$78K Buy
+841
New +$119K ﹤0.01% 2662
2021
Q2 		– Sell
-478
Closed -$240K – 3686
2021
Q1 		$240K Buy
+478
New +$245K ﹤0.01% 2580

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Squarepoint's TIL Position: Q4 2024 in Review

Squarepoint sold out of Instil Bio (TIL) in Q4 2024, closing a stake of 5,374 shares — an estimated $362K sold.

Squarepoint first reported a position in TIL in Q1 2021 and held it in 9 quarters. The position peaked at $362K in Q3 2024. 40 funds tracked by Wall St. Rank hold TIL as of Q4 2024.

  • Squarepoint reported no remaining Instil Bio position as of Q4 2024 after selling out during the quarter.
  • Squarepoint sold 5,374 Instil Bio shares in Q4 2024, an estimated $362K.
  • Squarepoint first reported a position in Instil Bio in Q1 2021 and held it in 9 quarters.
  • Squarepoint's Instil Bio position peaked at $362K in Q3 2024.
  • 40 funds tracked by Wall St. Rank held Instil Bio as of Q4 2024.

Based on Squarepoint's 13F filing for Q4 2024, filed 14 Feb 2025.